Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation

(2014) Madan Raj Aryal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Dabigatran in Catheter Ablation of Atrial Fibrillation: A Call for a Randomized Control Trial

(2014) Aref A. Bin Abdulhak et al.   AMERICAN JOURNAL OF CARDIOLOGY

Safety of Novel Oral Anticoagulants Compared With Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation

(2014) Heather L. Armbruster et al.   ANNALS OF PHARMACOTHERAPY

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

(2014) Atul Verma et al.   CANADIAN JOURNAL OF CARDIOLOGY

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

(2014) Luigi Di Biase et al.   CIRCULATION

Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

(2014) Jeffrey I. Weitz et al.   CIRCULATION

Safety of Continuous Periprocedural Rivaroxaban for Patients Undergoing Left Atrial Catheter Ablation Procedures

(2014) Roger Dillier et al.   Circulation-Arrhythmia and Electrophysiology

Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation

(2014) R. Providencia et al.   EUROPACE

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban

(2014) R. A. Winkle et al.   EUROPACE

Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

(2014) J. Chen et al.   EUROPACE

Complication rates of atrial fibrillation ablations: Comparison of safety outcomes from real world to contemporary randomized control trials

(2014) Naga Venkata K. Pothineni et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation

(2014) Gerald V. Naccarelli et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2014) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparative Safety of Periablation Anticoagulation Strategies for Atrial Fibrillation: Data from a Large Multicenter Study

(2014) AYSHA ARSHAD et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010

(2013) Abhishek Deshmukh et al.   CIRCULATION

Complications of Catheter Ablation of Atrial Fibrillation

(2013) Aakriti Gupta et al.   Circulation-Arrhythmia and Electrophysiology

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

(2012) H. Calkins et al.   EUROPACE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants

(2012) Gerald V. Naccarelli et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment

(2011) A. Hakalahti et al.   EUROPACE

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

(2011) Genevieve Contant et al.   THROMBOSIS AND HAEMOSTASIS

Catheter Ablation for Atrial Fibrillation on Uninterrupted Warfarin: Can It Be Done Without Echo Guidance?

(2010) STEPHEN P. PAGE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Effect of Therapeutic INR on Activated Clotting Times, Heparin Dosage, and Bleeding Risk During Ablation of Atrial Fibrillation

(2010) SANDEEP GAUTAM et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY